Vasorelaxant effects of purified green tea epicatechin derivatives in rat mesenteric artery

Life Sciences

Volumn 63, Issue 4, 1998, Pages 275-283

  Huang, Yu ^a,b   Zhang, Anqi ^a   Lau, Chi Wai ^a   Chen, Zhen Yu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Epicatechins; Green tea; Rat mesenteric artery; Relaxation

Indexed keywords

CAFFEINE; CHARYBDOTOXIN; ENDOTHELIN 1; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GLIBENCLAMIDE; NIFEDIPINE; PHENYLEPHRINE; PHORBOL 13 ACETATE 12 MYRISTATE; STAUROSPORINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; MESENTERIC ARTERY; NONHUMAN; RAT; TEA; VASODILATATION;

ANIMALS; CATECHIN; MALE; MESENTERIC ARTERIES; RATS; RATS, SPRAGUE-DAWLEY; TEA; VASOCONSTRICTOR AGENTS; VASODILATION;

ANIMALIA;

EID: 18144453111     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00273-2     Document Type: Article

References (20)

1. 1. K. IMAI and K. NAKACHI, Br. Med. J. 310 693-696 (1995).
2. 2. S. YOSHIZAWA, T. HORIUCHI, H. FUJIKI, T. YOSHIDA, T. OKUDA and T. SUGIMURA, Phytotherapy Res. 1 44-47 (1987)
3. 3. W. YOUNG, R.L. HOTOVEC and A.G. ROMERO, Nature 216 1015-1016 (1967).
4. 4. P. AKINYANJU and J. YUDKIN, Nature 214 426-427 (1967).
5. 5. K. MURAMATSU, M. FUKUYO and Y. HARA, J. Nutr. Sci. Vitaminol. 32 613-622 (1986).
6. 6. J.P. HENRY and P. STEPHENS-LARSON, Hypertension 6 437-444 (1984).
7. 7. T. EDEN, Langmans Green, London, pp: 136-148 (1958).
8. 8. A.Q. ZHANG, P.T. CHAN, Y.S. LUK, W.K.K. HO and Z.Y. CHEN, J. Nutri. Biochem. 8 334-340 (1997).
9. 9. R. AGARWAL, S.K. KATIYAR, S.I.A. ZAIDI and H. MUKNTAR, Cancer Res. 52 3582-3588 (1992).
10. 10. Z.Y. CHEN and P.T. CHAN, Chem. Phys. Lipids 82 163-172 (1996).
11. 11. E.Jr. MIDDLETON, Trends. Biol. Sci. 5 335-338 (1984).
12. 12. J. DURATE, F. PEREZ-VIZCAINO, P. UTRILLA, J. JIMENEZ and J. TAMARGO, Eur. J. Pharmacol. 239 1-7 (1993).
13. 13. C.A. RICE-EVANS, N.J. LIMMER and G. PAGANGA, Free Rad. Biol. Med. 20 933-956 (1996).
14. 14. R.Uc.M. VILLALOBOS-MOLINA, G. HONG and J.A. CARCIA-SAINZ, J. Pharmacol. Exp. Ther. 222 258-261 (1982).
15. 15. M.S. SHEARMAN, K. SEKIGUCHI and Y. NISHIZUKA, Pharmacol. Rev. 41 211-237 (1989).
16. 16. Y. LIU, B. GEISBUHLER and A.W. JONES, Am. J. Physiol. 262 C941-C949 (1992).
17. 17. C.VAN. BREEMEN, and E. McNAUGHTON, Biochem. Biophys. Res. Commun. 39 567-574 (1970).
18. 18. P. LRIJTEN and C.VAN. BREEMEN, J. Physiol. 357 327-339 (1984).
19. 19. H.Y. AHN and H. KARAKI, Br. J. Pharmacol. 94 789-796 (1988).
20. 20. P.C. FERRIOLA, V. CODY and E.Jr. MIDDLETON, Biochem. Pharmacol. 38 1617-1624 (1989).